Fadini, G. P., Sarangdhar, M., De Ponti, F., Avogaro, A., & Raschi, E. (2019). Pharmacovigilance assessment of the association between Fournier’s gangrene and other severe genital adverse events with SGLT-2 inhibitors. BMJ Open Diabetes Res Care.
Citação norma ChicagoFadini, Gian Paolo, Mayur Sarangdhar, Fabrizio De Ponti, Angelo Avogaro, and Emanuel Raschi. "Pharmacovigilance Assessment of the Association between Fournier’s Gangrene and Other Severe Genital Adverse Events With SGLT-2 Inhibitors." BMJ Open Diabetes Res Care 2019.
MLA CitationFadini, Gian Paolo, et al. "Pharmacovigilance Assessment of the Association between Fournier’s Gangrene and Other Severe Genital Adverse Events With SGLT-2 Inhibitors." BMJ Open Diabetes Res Care 2019.